DK3027063T3 - Opo-glyceridsammensætning - Google Patents

Opo-glyceridsammensætning Download PDF

Info

Publication number
DK3027063T3
DK3027063T3 DK14747618.8T DK14747618T DK3027063T3 DK 3027063 T3 DK3027063 T3 DK 3027063T3 DK 14747618 T DK14747618 T DK 14747618T DK 3027063 T3 DK3027063 T3 DK 3027063T3
Authority
DK
Denmark
Prior art keywords
opo
composition
glyceride
alpha
weight
Prior art date
Application number
DK14747618.8T
Other languages
English (en)
Inventor
Luisa Gambelli
Randolph Happe
Sebastiano Banni
Original Assignee
Bunge Loders Croklaan B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48900910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3027063(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bunge Loders Croklaan B V filed Critical Bunge Loders Croklaan B V
Application granted granted Critical
Publication of DK3027063T3 publication Critical patent/DK3027063T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (7)

1. 1,3-dioleoyl-2-palmitoylglycerid (ΟΡΟ) til anvendelse ved udvikling og/eller forbedring af hjernefunktion, beskyttelse mod neuroinflammation eller behandling og/eller lindring af misbrug eller Alzheimers sygdom.
2. OPO til anvendelse ifølge krav 1, hvor OPO er afledt af en vegetabilsk kilde.
3. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er fremstillet ved omsætning af palmeoliestearin med oliesyre eller en ester deraf i nærvær af en lipase.
4. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er i form af en sammensætning, som omfatter alpha-linolensyre eller et glycerid deraf i en mængde på mere end 1 vægt-% alpha-linolensyre baseret på de samlede frie og bundne C6-til C24-fedtsyrer og/eller linolsyre eller et glycerid deraf, og hvor vægtforholdet mellem samlet fri og bunden linolsyre og samlet fri og bundet alpha-linolensyre fortrinsvis er 15:1 eller mindre.
5. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er i form af en blanding omfattende (i) en sammensætning omfattende alpha-linolensyre eller et glycerid deraf og (ii) en triglyceridsammensætning omfattende OPO i en mængde på mindst 20 vægt-%, og hvor sammensætningen omfattende alpha-linolensyre eller et glycerid deraf fortrinsvis er en vegetabilsk olie.
6. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er i form afen sammensætning, som er uden phospholipider.
7. OPO til anvendelse ifølge et hvilket som helst af de foregående krav, hvor OPO er i form af en sammensætning, som er en modermælkserstatning yderligere omfattende protein, kulhydrat, mineraler og vitaminer.
DK14747618.8T 2013-08-01 2014-07-31 Opo-glyceridsammensætning DK3027063T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13275180 2013-08-01
PCT/EP2014/066549 WO2015014967A1 (en) 2013-08-01 2014-07-31 Glyceride composition

Publications (1)

Publication Number Publication Date
DK3027063T3 true DK3027063T3 (da) 2019-02-18

Family

ID=48900910

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14747618.8T DK3027063T3 (da) 2013-08-01 2014-07-31 Opo-glyceridsammensætning

Country Status (7)

Country Link
US (1) US20160166527A1 (da)
EP (1) EP3027063B1 (da)
KR (1) KR20160041952A (da)
CN (1) CN105517452A (da)
DK (1) DK3027063T3 (da)
NZ (1) NZ716341A (da)
WO (1) WO2015014967A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3027063B1 (en) 2013-08-01 2018-11-21 Bunge Loders Croklaan B.V. Opo glyceride composition
EP3466277A1 (en) 2013-11-01 2019-04-10 N.V. Nutricia Lipid composition for improving body composition during catch-up growth
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
FI3874959T3 (fi) * 2016-12-09 2024-08-09 Nutricia Nv Ravintokoostumus käytettäväksi kognitiivisen toimintakyvyn parantamisessa ja/tai kognitiivisen heikentymisen ehkäisemisessä
CN108265089B (zh) * 2016-12-30 2021-06-11 中粮集团有限公司 一种含有1,3-二油酸-2-棕榈酸甘油三酯的油脂组合物及其制备方法
KR102036556B1 (ko) * 2018-06-26 2019-10-25 주식회사 삼양사 고-올레산 해바라기유의 사용에 의하여 효소적 에스테르화의 효율을 향상시키는 방법
JP6797269B2 (ja) * 2018-11-20 2020-12-09 花王株式会社 油脂組成物
CN112195199A (zh) * 2020-10-29 2021-01-08 赞宇科技集团股份有限公司 一种1，3-二油酸-2-棕榈酸甘油三酯的生产方法
CN113699191A (zh) * 2021-10-19 2021-11-26 江南大学 一种2-花生四烯酸甘油一酯的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
GB2178752B (en) 1985-07-12 1989-10-11 Unilever Plc Substitute milk fat
JP2826808B2 (ja) * 1995-07-14 1998-11-18 カルピス株式会社 脳機能改善、学習能力増強および記憶力増強作用を有する機能性食品
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
IL158554A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
IL158555A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
JP2008538915A (ja) * 2005-04-27 2008-11-13 エンジィモテック リミテッド ヒト乳脂代用物
ES2394951T3 (es) * 2005-09-08 2013-02-07 Loders Croklaan B.V. Proceso para la producción de triglicéridos
AU2006288937B2 (en) 2005-09-08 2010-08-26 Loders Croklaan B.V. Process for producing dioleoyl palmitoyl glyceride
NZ579108A (en) * 2007-02-28 2011-02-25 Loders Croklaan Bv Process for producing 1,3,-dioleoyl-2-palmitoyl glyceride (OPO)
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
RU2611808C2 (ru) * 2007-11-01 2017-03-01 Энзимотек Лтд. Липидная смесь для детского питания
EP3027063B1 (en) 2013-08-01 2018-11-21 Bunge Loders Croklaan B.V. Opo glyceride composition

Also Published As

Publication number Publication date
NZ716341A (en) 2018-02-23
KR20160041952A (ko) 2016-04-18
CN105517452A (zh) 2016-04-20
EP3027063A1 (en) 2016-06-08
WO2015014967A1 (en) 2015-02-05
US20160166527A1 (en) 2016-06-16
EP3027063B1 (en) 2018-11-21

Similar Documents

Publication Publication Date Title
DK3027063T3 (da) Opo-glyceridsammensætning
US9695384B2 (en) Process for producing a glyceride composition
US8183021B2 (en) Process for producing triglycerides
DK1928990T3 (da) Fremgangsmåde til fremstilling af dioleylpalmitoylglycerid
DK2956010T3 (da) Fedtsammensætning
DK2219476T3 (da) Modermælkserstatningssammensætning
US7604966B2 (en) Process for the production of structured lipid mixtures
EP2173197A2 (en) Process
EP2845490A1 (en) Fat composition for improved body fat distribution
WO2015050220A1 (ja) 油脂組成物
AU2015311021C9 (en) Composition